Back to Browse Journals » Journal of Inflammation Research » Volume 3

Inflammatory cytokines and atrial fibrillation: current and prospective views

Authors Hadi AR Hadi, Alawi A Alsheikh-Ali, Wael AL Mahmeed, et al.

Published 30 August 2010 Volume 2010:3 Pages 75—97


Review by Single-blind

Peer reviewer comments 3

Hadi AR Hadi, Alawi A Alsheikh-Ali, Wael AL Mahmeed, Jassim M Al Suwaidi

Institute of Cardiac Sciences, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates

Abstract: Atrial fibrillation (AF) is the most common sustained arrhythmia and a ­challenging clinical problem encountered in daily clinical practice. There is an increasing body of evidence linking inflammation to a broad spectrum of cardiovascular conditions including AF. Historical evidence supports an association between AF and inflammation and is consistent with the association of AF with inflammatory conditions of the heart, such as myocarditis and pericarditis. AF has been associated with myocardial oxidative stress, and antioxidant agents have demonstrated antiarrhythmic benefit in humans. Increased plasma interleukin (IL)-6, C-reactive protein (CRP), and plasma viscosity support the existence of an inflammatory state among “typical” populations with chronic AF. These indexes of inflammation are related to the prothrombotic state and may be linked to the clinical characteristics of the patients (underlying vascular disease and comorbidities), rather than simply to the presence of AF itself. It has been suggested that inflammation may have a role in the development of atrial arrhythmias after cardiac surgery, and that a genetic predisposition to develop postoperative complications exists. Cytokines can have a prognostic significance; IL-6 levels, CRP, and other cytokines may have prognostic value in AF. Cytokine lowering therapies, statins, angiotensin converting enzyme inhibitors and other anti-inflammatory agents may have a role in the treatment of AF. The present article provides an overview of the evidence linking inflammatory cytokines to AF and their therapeutic and prognostic implications.

Keywords: atrial fibrillation, inflammation, cytokines

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 


Other article by this author:

Pleiotropic effects of statins in atrial fibrillation patients: the evidence

Hadi AR Hadi, Wael Al Mahmeed, Jassim Al Suwaidi, Samer Ellahham

Vascular Health and Risk Management 2009, 5:533-551

Published Date: 17 June 2009

Readers of this article also read:

Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease

Pisi R, Aiello M, Zanini A, Tzani P, Paleari D, Marangio E, Spanevello A, Nicolini G, Chetta A

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1191-1197

Published Date: 19 June 2015

Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature

Lizán L, Comellas M, Paz S, Poveda JL, Meletiche DM, Polanco C

Patient Preference and Adherence 2014, 8:1653-1664

Published Date: 4 December 2014

Effect of administration of water enriched in O2 by injection or electrolysis on transcutaneous oxygen pressure in anesthetized pigs

Charton A, Péronnet F, Doutreleau S, Lonsdorfer E, Klein A, Jimenez L, Geny B, Diemunsch P, Richard R

Drug Design, Development and Therapy 2014, 8:1161-1167

Published Date: 26 August 2014

Nasal saline as a placebo in a rhinosinusitis study

Karadag A, Catal F

Drug Design, Development and Therapy 2014, 8:1135-1137

Published Date: 20 August 2014

Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation

Pathak R, Enuh HA, Patel A, Wickremesinghe P

Clinical and Experimental Gastroenterology 2014, 7:1-6

Published Date: 27 December 2013

Clinical and immunological evaluation after BCG-id vaccine in leprosy patients in a 5-year follow-up study

Zenha EM, Wambier CG, Novelino AL, Andrade TA, Ferreira MA, Frade MA, Foss NT

Journal of Inflammation Research 2012, 5:125-135

Published Date: 18 December 2012

Novel multi-biotin grafted poly(lactic acid) and its self-assembling nanoparticles capable of binding to streptavidin

Yan H, Jiang W, Zhang Y, Liu Y, Wang B, Yang L, Deng L, Singh GK, Pan J

International Journal of Nanomedicine 2012, 7:457-465

Published Date: 31 January 2012

Physicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment

Yang D, Van S, Liu J, Wang J, Jiang X, Wang Y, Yu L

International Journal of Nanomedicine 2011, 6:2557-2566

Published Date: 21 October 2011

Argatroban in the management of heparin-induced thrombocytopenia

Luciano Babuin, Vittorio Pengo

Vascular Health and Risk Management 2010, 6:813-819

Published Date: 1 September 2010